Abstract
Background: Sentinel lymph node biopsy is now the recognised technique for staging of the axilla in early breast cancer. National Institute of Clinical Excellence, United Kingdom, guidelines advise the use of a dual technique in identifying the sentinel lymph node. However, national restrictions in the supply of Technetium99 have created a real problem in delivering this gold standard. We studied an alternative magnetic tracer (Magtrace®, Endolab) to use as an adjunct to Patent Blue dye (Guerbet Laboratories) in axillary staging.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
